AC
RCKT icon

Athanor Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Athanor Capital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,819
Closed -$303K – 694
2021
Q1 		$303K Buy
6,819
+660
+11% +$36.2K 0.01% 595
2020
Q4 		$338K Sell
6,159
-2,651
-30% -$96.6K 0.01% 554
2020
Q3 		$201K Sell
8,810
-2,821
-24% -$69.5K 0.01% 492
2020
Q2 		$243K Buy
+11,631
New +$210K 0.01% 458
2020
Q1 		– Sell
-10,801
Closed -$246K – 303
2019
Q4 		$246K Buy
+10,801
New +$180K 0.01% 331

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Athanor Capital's RCKT Position: Q2 2021 in Review

Athanor Capital sold out of Rocket Pharmaceuticals (RCKT) in Q2 2021, closing a stake of 6,819 shares — an estimated $303K sold.

Athanor Capital first reported a position in RCKT in Q4 2019 and held it in 5 quarters. The position peaked at $338K in Q4 2020. 150 funds tracked by Wall St. Rank hold RCKT as of Q2 2021.

  • Athanor Capital reported no remaining Rocket Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 6,819 Rocket Pharmaceuticals shares in Q2 2021, an estimated $303K.
  • Athanor Capital first reported a position in Rocket Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Athanor Capital's Rocket Pharmaceuticals position peaked at $338K in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.